The generosity of plasma donors has a profound impact on patients like me

For many with bleeding disorders, plasma-derived therapies are the only option

Written by Jennifer Lynne |

Banner image for

There are moments when I’m reminded just how much I depend on something most people rarely think about.

I live with von Willebrand disease, and my treatment depends on Humate-P (antihemophilic factor/von Willebrand factor complex [human]), a plasma-derived therapy. This medication is more than just a vial; it is my sense of security, the force that controls bleeding episodes and allows me to live without constant fear. Yet, unlike synthetic drugs, this lifeline cannot be manufactured in a factory. It exists solely because of human generosity.

The connection between a donor and a patient like me is both incredibly powerful and strikingly fragile. What many people don’t realize is the sheer scale of that connection. To create just a single dose of a therapy like Humate-P, plasma must be pooled from thousands of individual donations. When I infuse, I am not relying on one hero; I am relying on an entire stadium of them.

Recommended Reading
A man in a hospital bed looks up at his IV bag.

New study finds better mental health linked to adherence in hemophilia

For the bleeding disorders community, plasma-derived therapies aren’t just one of many options. For many, they are the only option. However, the supply chain behind them is often invisible, and when donations drop, the uncertainty for patients is not abstract. It is a chilling reality of potential shortages and lost stability.

The most vital part of this system is the donor. Most donors will never meet the person whose life they’ve changed. They may never see me travel, attend family events, or simply wake up with the confidence to face the day. Yet their impact is profound. Every infusion I take is a quiet partnership between medical science and human kindness.

PPTA global survey

This is why understanding and protecting the plasma supply is a mission we must all share. The Plasma Protein Therapeutics Association (PPTA) has launched a global survey to gather insights from those of us who rely on these therapies. It is an opportunity for our lived experiences to move the needle, ensuring the system that supports us is strengthened for the future.

If you have ever considered donating plasma, please know that your decision carries life-altering weight. You aren’t just giving a component of your blood; you are giving a patient their independence, their health, and their future. If you are part of our community, I urge you to lend your voice to the PPTA survey. Whether by donating or sharing your story, you help ensure this lifeline never breaks.

Behind every treatment is a person. And behind every person like me is a community of donors we may never see, but whom we deeply, eternally rely on.


Note: Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or another qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Hemophilia News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to hemophilia.

Leave a comment

Fill in the required fields to post. Your email address will not be published.